TCM
RVNC

Tang Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Tang Capital Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,500,000
Closed -$13M – 193
2024
Q3 		$13M Buy
2,500,000
+2,100,000
+525% +$10.4M 0.93% 34
2024
Q2 		$1.03M Buy
400,000
+200,000
+100% +$683K 0.1% 93
2024
Q1 		$984K Buy
+200,000
New +$1.18M 0.1% 88
2022
Q4 		– Sell
-287,500
Closed -$7.76M – 107
2022
Q3 		$7.76M Buy
+287,500
New +$5.83M 0.95% 32

Other funds holding RVNC

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $109M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return